Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
J Med Virol
; 93(2): 775-785, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1196401
ABSTRACT
Treatment options for severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) are limited with no clarity on efficacy and safety profiles. We performed a systematic review and meta-analysis of studies on patients ≥18 years reporting data on therapeutic interventions in SARS-CoV-2. Primary outcome was all-cause mortality and secondary outcomes were rates of mechanical ventilation, viral clearance, adverse events, discharge, and progression to severe disease. Pooled rates and odds ratios (OR) were calculated. Twenty-nine studies with 5207 patients were included. Pooled all-cause mortality in intervention arm was 12.8% (95% confidence interval [CI] 8.1%-17.4%). Mortality was significantly higher for studies using hydroxychloroquine (HCQ) for intervention (OR 1.36; 95% CI 0.97-1.89). Adverse events were also higher in HCQ subgroup (OR 3.88; 95% CI 1.60-9.45). There was no difference in other secondary outcomes. There is a need for well-designed randomized clinical trials for further investigation of every therapeutic intervention for further insight into different therapeutic options.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Antivirales
/
Adenosina Monofosfato
/
Corticoesteroides
/
Ritonavir
/
Alanina
/
Lopinavir
/
Anticuerpos Monoclonales Humanizados
/
COVID-19
/
Hidroxicloroquina
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
/
Ensayo controlado aleatorizado
/
Revisiones
/
Revisión sistemática/Meta análisis
Límite:
Femenino
/
Humanos
/
Masculino
/
Middle aged
Idioma:
Inglés
Revista:
J Med Virol
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS